Should vascular effects of newer treatments be addressed more completely?

Eric H. Yang, Karol E. Watson, Joerg Herrmann

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)1995-1998
Number of pages4
JournalFuture Oncology
Issue number14
StatePublished - Jul 1 2015


  • cardio-oncology
  • cardiotoxicity
  • dasatinib
  • imatinib resistance
  • leukemia
  • nilotinib
  • peripheral arterial disease
  • ponatinib
  • tyrosine kinase inhibitors
  • vascular toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this